Opinion/decision on a Paediatric investigation plan (PIP): Isturisa, osilodrostat, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Endocrine disorders, PIP number: P/0325/2024

Human medicines European public assessment report (EPAR): Bortezomib Sun, bortezomib, Date of authorisation: 22/07/2016, Revision: 15, Status: Authorised

Opinion/decision on a Paediatric investigation plan (PIP): Nulojix, belatacept, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Renal and urinary disorders, PIP number: P/0351/2024

Veterinary medicines European public assessment report (EPAR): Ubac, Streptococcus uberis vaccine (inactivated), Status: Authorised

Veterinary medicines European public assessment report (EPAR): Tulissin, tulathromycin, Status: Authorised

Veterinary medicines European public assessment report (EPAR): Tulinovet, tulathromycin, Status: Authorised

Veterinary medicines European public assessment report (EPAR): Tulaven, tulathromycin, Status: Authorised

EMA/PE/0000227301

Human medicines European public assessment report (EPAR): Menveo, meningococcal group A, C, W-135 and Y conjugate vaccine, Date of authorisation: 15/03/2010, Date of refusal: 17/12/2009, Revision: 39, Status: Authorised

IRIS guide for applicants - How to create, submit and manage IRIS applications, for industry and individual applicants